0
Cancer Research: What is the sensitivity and specificity of the BRCA1 and 2 mutations?
- 1 people answered
0 Vote
1 Contributor
1298 Views 
0 Saved
0 Vote 1 Contributor1298 Views 0 SavedYou might also be interested in
As you know, chemotherapy, radiation and surgery, along with targeted treatments, gene therapy, laser and a few others are the standard traditional procedures for cancer treatment; they are called that because they have a proven track record and you can look up research results and find out that tho....
Yes…!! It is safe for health. This fruit looks like a small pumpkin and is green to pale yellow in colour. It is one of the most popular natural diet supplements. It contains Hydroxy citric acid (HCA) that is obtained from its rind and it is capable of burning fats much faster than other supple....
The risk is so low that it is impossible to read using tables of published health data and statistics. Children do get cancer, but very rarely breast cancer. Statistics will often group women aged 15–39 as “young women” but this is very misleading as the bump in cases begins in women over 20, or eve....
Nidii Berwal
Genes and genetic variations in our body contribute to the bodily functions and overall health. This also includes the possibility of having various diseases which are hereditary or developed in our body due to changes in the genetic codes. BRCA -1 & BRCA – 2 are two genes which are linked to Hereditary Breast and Ovarian Cancer. These genes produce tumor suppressor proteins which help to repair damaged DNA. When either of these genes have mutations, it increases the risk of cancer. BRCA 1 & BRCA 2 testing should be considered if: You had breast cancer at early age Your mother, sister, or daughter had breast cancer at early age or ovarian cancer. You are a woman with 1st degree relative who’s diagnosed with bilateral breast cancer before age of 50 The men in your family have strong history of breast/ ovarian cancer. Women who have BRCA 1 gene mutation are at higher risk of triple negative breast cancer while BRCA 2 carriers have breast cancers that are Estrogen Receptor positive. BRCA 1/2 mutations increase the risk of ovarian cancer.